Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease

Ravi Vats,Silvia Liu,Junjie Zhu,Dhanunjay Mukhi,Egemen Tutuncuoglu,Nayra Cardenes,Sucha Singh,Tomasz Brzoska,Karis Kosar,Mikhil Bamne,Jude Jonassaint,Adeola Adebayo Michael,Simon C. Watkins,Cheryl Hillery,Xiaochao Ma,Kari Nejak‐Bowen,Mauricio Rojas,Mark T. Gladwin,Gregory J. Kato,Sadeesh Ramakrishnan,Prithu Sundd,Satdarshan Pal Monga,Tirthadipa Pradhan‐Sundd

DOI: https://doi.org/10.1002/hep.31239

IF: 17.298

2020-11-13

Hepatology

Abstract:<p>Hepatic crisis is an emergent complication affecting sickle cell disease (SCD) patients, however, the molecular mechanism of sickle cell hepatobiliary injury remains poorly understood. Using the knock‐in humanized mouse model of SCD and SCD patient blood, we sought to mechanistically characterize SCD‐associated hepato‐pathophysiology applying our recently developed quantitative liver intravital imaging, RNA sequence analysis, and biochemical approaches. SCD mice manifested sinusoidal ischemia, progressive hepatomegaly, liver injury, hyperbilirubinemia, and increased ductular reaction under basal conditions. NF‐κB activation in the liver of SCD mice inhibited FXR signaling and its downstream targets, leading to loss of canallicular bile transport and altered bile acid pool. Intravital imaging revealed impaired bile secretion into the bile canaliculi, which was secondary to loss of canallicular bile transport and bile acid metabolism, leading to intrahepatic bile accumulation in SCD mice liver. Blocking NF‐κB activation rescued FXR‐signaling, and partially ameliorated liver injury and sinusoidal ischemia in SCD mice. These findings are the first to identify that NF‐κB‐FXR dependent impaired bile secretion promotes intrahepatic bile accumulation, which contributes to hepatobiliary injury of SCD. Improved understanding of these processes could potentially benefit the development of new therapies to treat sickle cell hepatic crisis.</p>

gastroenterology & hepatology